{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:01Z","timestamp":1793409661477,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T00:00:00Z","timestamp":1271980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00431-010-1179-6","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T18:01:58Z","timestamp":1271959318000},"page":"1069-1074","source":"Crossref","is-referenced-by-count":37,"title":["The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population"],"prefix":"10.1007","volume":"169","author":[{"given":"Hamid","family":"Naamane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouafaa","family":"El Maataoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Ailal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilali","family":"Najib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Hassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Saile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Aziz","family":"Bousfiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,23]]},"reference":[{"key":"1179_CR1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0929-693X(97)88145-6","volume":"4","author":"M Bejaoui","year":"1997","unstructured":"Bejaoui M, Barbouche MR, Dellagi K (1997) Les d\u00e9ficits immunitaires primitifs en Tunisie; \u00e9tude de 152 cas. Arch P\u00e9diatr 4:827\u2013831","journal-title":"Arch P\u00e9diatr"},{"key":"1179_CR2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0929-693X(99)80005-0","volume":"5","author":"M Bejaoui","year":"1998","unstructured":"Bejaoui M, Barbouche MR, Mellouli F et al (1998) D\u00e9ficit immunitaire primitif par d\u00e9faut d\u2019expression des antig\u00e8nes de classe II: neuf observations tunisiennes. Arch Pediatr 5:1089\u20131093","journal-title":"Arch Pediatr"},{"key":"1179_CR3","first-page":"435","volume":"41","author":"M Benallegue","year":"1984","unstructured":"Benallegue M, Kedjif F (1984) Consanguinit\u00e9 et sant\u00e9 publique, \u00e9tude alg\u00e9rienne. Arch Fr P\u00e9diatr 41:435\u2013440","journal-title":"Arch Fr P\u00e9diatr"},{"key":"1179_CR4","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.88.10.4285","volume":"88","author":"B Benichou","year":"1991","unstructured":"Benichou B, Strominger JL (1991) Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distint genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88:4285\u20134288","journal-title":"Proc Natl Acad Sci USA"},{"key":"1179_CR5","first-page":"5","volume":"18","author":"AA Bousfiha","year":"2008","unstructured":"Bousfiha AA, Ailal F, Picard C et al (2008) Epid\u00e9miologie et classification des d\u00e9ficits immunitaires primitifs. Rev Mar Mal Enf 18:5\u201311","journal-title":"Rev Mar Mal Enf"},{"key":"1179_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.iy.12.040194.001355","volume":"12","author":"P Cresswell","year":"1994","unstructured":"Cresswell P (1994) Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 12:259\u2013293","journal-title":"Annu Rev Immunol"},{"key":"1179_CR7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/emboj\/16.5.1045","volume":"16","author":"B Durant","year":"1997","unstructured":"Durant B, Sperisen P, Emery P et al (1997) RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J 16:1045\u20131055","journal-title":"EMBO J"},{"key":"1179_CR8","doi-asserted-by":"crossref","unstructured":"Geha RS, Notarangelo LD, Casanova JL et al (2007) International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","DOI":"10.1016\/j.jaci.2005.12.1347"},{"key":"1179_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0090-1229(05)80045-5","volume":"61","author":"C Griscelli","year":"1991","unstructured":"Griscelli C (1991) Combined immunodeficiency with defective expression in MHC class II genes. Clin Immunol Immunopath 61:106\u2013110","journal-title":"Clin Immunol Immunopath"},{"key":"1179_CR10","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/0090-1229(89)90121-9","volume":"50","author":"C Griscelli","year":"1989","unstructured":"Griscelli C, Lisowska-Grospierre B, Le Deist F et al (1989) Combined immunodeficiency with abnormal expression of MHC class II genes. Clin Immunol Immunopathol 50:S140\u2013S148","journal-title":"Clin Immunol Immunopathol"},{"key":"1179_CR11","first-page":"141","volume-title":"Immunodeficiencies","author":"C Griscelli","year":"1993","unstructured":"Griscelli C, Lisowska-Grospierre B, Mach B et al (1993) Combined immunodeficiency with defective expression in MHC class II genes. In: Rosen FS, Seligman M (eds) Immunodeficiencies. Harwood Academic, Chur, Switzerland, p 141"},{"key":"1179_CR12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0198-8859(89)90007-4","volume":"26","author":"CR Hume","year":"1989","unstructured":"Hume CR, Lee JS (1989) Congenital immunodeficiency associated with absence of HLA class II antigens on lymphocyte result from distinct mutations in transacting factors. Hum Immunol 26:288\u2013309","journal-title":"Hum Immunol"},{"issue":"6","key":"1179_CR13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(05)80388-9","volume":"123","author":"C Klein","year":"1993","unstructured":"Klein C, Lisowska-Grospierre B, Ledeist F et al (1993) Major histocompatibility complex class II deficiency: clinical manifestations, immunological features and outcome. J Pediatr 123(6):921\u2013928","journal-title":"J Pediatr"},{"key":"1179_CR14","first-page":"183","volume":"67","author":"M Krawczyk","year":"2006","unstructured":"Krawczyk M, Reith W (2006) Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Journal compilation 67:183\u2013197","journal-title":"Journal compilation"},{"key":"1179_CR15","first-page":"1013","volume":"178","author":"N Lamdaouer Bouazzaoui","year":"1994","unstructured":"Lamdaouer Bouazzaoui N (1994) Consanguinit\u00e9 et Sant\u00e9 publique au Maroc. Bull Acad Natle Med 178:1013\u20131027","journal-title":"Bull Acad Natle Med"},{"key":"1179_CR16","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.166.9.5681","volume":"166","author":"AM Lennon-Dumenil","year":"2001","unstructured":"Lennon-Dumenil AM, Barbouche MR, Vedrenne J et al (2001) Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency. J Immunol 166:5681\u20135687","journal-title":"J Immunol"},{"key":"1179_CR17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/hmg\/3.6.953","volume":"3","author":"B Lisowska-Grospierre","year":"1994","unstructured":"Lisowska-Grospierre B, Fondaneche MC, Rols MP et al (1994) Two complementation groups accent for most cases of inherited MHC class II deficiency. Hum Mol Genet 3:953\u2013958","journal-title":"Hum Mol Genet"},{"key":"1179_CR18","first-page":"153","volume":"10","author":"B Mach","year":"1996","unstructured":"Mach B, Steimle V, Martinez-Soria E, Reith W (1996) Regulation of MHC class genes: lessons from a disease. Annu Rev Immunol 10:153\u2013331","journal-title":"Annu Rev Immunol"},{"key":"1179_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/3081","volume":"20","author":"K Masternak","year":"1998","unstructured":"Masternak K, Barras E, Zufferey M et al (1998) A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet 20:273\u2013277","journal-title":"Nat Genet"},{"key":"1179_CR20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gad.14.9.1156","volume":"14","author":"K Masternak","year":"2000","unstructured":"Masternak K, Muhlethaler-Mottet A, Villard J et al (2000) CIITA is a transcriptional coactivator that is recruited to MHC II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 14:1156\u20131166","journal-title":"Genes Dev"},{"key":"1179_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1074-7613(00)80016-3","volume":"10","author":"UM Nagarajan","year":"1999","unstructured":"Nagarajan UM, Louis-Plence P, DeSandro A et al (1999) RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10:153\u2013162","journal-title":"Immunity"},{"key":"1179_CR22","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.4049\/jimmunol.164.7.3666","volume":"164","author":"UM Nagarajan","year":"2000","unstructured":"Nagarajan UM, Peijnenburg A, Gobin SJ et al (2000) Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J Immunol 164:3666\u20133674","journal-title":"J Immunol"},{"key":"1179_CR23","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1128\/MCB.21.16.5566-5576.2001","volume":"21","author":"N Nekrep","year":"2001","unstructured":"Nekrep N, Geyer M, Jabrane-Ferrat N, Peterlin BM (2001) Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. Mol Cell Biol 21:5566\u20135576","journal-title":"Mol Cell Biol"},{"key":"1179_CR24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002510050501","volume":"49","author":"A Peijnenburg","year":"1999","unstructured":"Peijnenburg A, Van Eggermond MC, Van der Berg R et al (1999) Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 49:338\u2013345","journal-title":"Immunogenetics"},{"key":"1179_CR25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0092-8674(88)90389-3","volume":"53","author":"W Reith","year":"1988","unstructured":"Reith W, Satola S, Sanchez CH et al (1988) Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897\u2013906","journal-title":"Cell"},{"issue":"Suppl. 1","key":"1179_CR26","first-page":"1","volume":"118","author":"Report of an IUIS Scientific Group","year":"1999","unstructured":"Report of an IUIS Scientific Group (1999) Primary immunodeficiency diseases. Clin Exp Immunol 118(suppl 1):1\u201328","journal-title":"Clin Exp Immunol"},{"key":"1179_CR27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.83.4.356","volume":"83","author":"MA Saleem","year":"2000","unstructured":"Saleem MA, Arkwright PD, Davies EG et al (2000) Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child 83:356\u2013359","journal-title":"Arch Dis Child"},{"issue":"5","key":"1179_CR28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer WT, Rosenblatt HM, Gelman RS et al (2003) Lymphocyte subsets in healthy children from birth through 18\u00a0years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112(5):973\u2013980","journal-title":"J Allergy Clin Immunol"},{"key":"1179_CR29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1101\/gad.9.9.1021","volume":"9","author":"V Steimle","year":"1995","unstructured":"Steimle V, Durant B, Barras E et al (1995) A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021\u20131032","journal-title":"Genes Dev"},{"key":"1179_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0092-8674(93)90685-J","volume":"75","author":"V Steimle","year":"1993","unstructured":"Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135\u2013146","journal-title":"Cell"},{"key":"1179_CR31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle V, Siegrist CA, Mottet A et al (1994) Regulation of MHC class II expression by interferon mediated by the transactivator gene CIITA. Science 265:106\u2013109","journal-title":"Science"},{"key":"1179_CR32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1056\/NEJM199709113371104","volume":"337","author":"J Villard","year":"1997","unstructured":"Villard J, Lisowska-Grospierre B, Van der Elsen P et al (1997) Mutation of RFXAP, a regulator MHC class II gene, in primary MHC class II deficiency. N Engl J Med 337:748\u2013753","journal-title":"N Engl J Med"},{"key":"1179_CR33","volume-title":"Protein reference unit handbook of clinical immunochemistry","author":"AM Ward","year":"1998","unstructured":"Ward AM (1998) Protein reference unit handbook of clinical immunochemistry, 2nd edn. PRU Publications, Sheffield","edition":"2"},{"key":"1179_CR34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s002510050619","volume":"51","author":"W Wiszniewski","year":"2000","unstructured":"Wiszniewski W, Fondaneche MC, Lambert N et al (2000) Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics 51:261\u2013267","journal-title":"Immunogenetics"},{"key":"1179_CR35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00251-002-0521-1","volume":"54","author":"W Wiszniewski","year":"2003","unstructured":"Wiszniewski W, Fondaneche MC, Louise-Plence P et al (2003) Novel mutations in the RFXANK gene: RFX complex containing in vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. Immunogenetics 54:747\u2013755","journal-title":"Immunogenetics"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1179-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-010-1179-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1179-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:24:10Z","timestamp":1711412650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-010-1179-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,23]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s00431-010-1179-6","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,23]]}}}